PERNA, Alessandra
 Distribuzione geografica
Continente #
EU - Europa 12.064
NA - Nord America 4.973
AS - Asia 4.490
SA - Sud America 868
AF - Africa 51
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 22.458
Nazione #
RU - Federazione Russa 7.330
US - Stati Uniti d'America 4.914
SG - Singapore 1.620
IE - Irlanda 1.310
CN - Cina 918
IT - Italia 814
HK - Hong Kong 757
BR - Brasile 746
UA - Ucraina 597
GB - Regno Unito 529
DE - Germania 472
FR - Francia 386
IN - India 385
VN - Vietnam 242
KR - Corea 204
SE - Svezia 176
FI - Finlandia 167
TR - Turchia 165
GR - Grecia 107
JP - Giappone 59
AT - Austria 48
AR - Argentina 45
BE - Belgio 33
BD - Bangladesh 28
EC - Ecuador 27
NL - Olanda 25
MX - Messico 22
CA - Canada 21
PK - Pakistan 18
IQ - Iraq 16
ZA - Sudafrica 16
ID - Indonesia 15
PL - Polonia 14
AE - Emirati Arabi Uniti 11
CZ - Repubblica Ceca 11
PE - Perù 11
CO - Colombia 9
UZ - Uzbekistan 9
VE - Venezuela 9
SA - Arabia Saudita 8
DK - Danimarca 7
ES - Italia 7
MA - Marocco 7
UY - Uruguay 6
AL - Albania 5
CL - Cile 5
EU - Europa 5
PY - Paraguay 5
RS - Serbia 5
AO - Angola 4
AU - Australia 4
AZ - Azerbaigian 4
CH - Svizzera 4
DO - Repubblica Dominicana 4
HN - Honduras 4
KE - Kenya 4
KZ - Kazakistan 4
PH - Filippine 4
BO - Bolivia 3
EG - Egitto 3
LT - Lituania 3
NP - Nepal 3
PA - Panama 3
PS - Palestinian Territory 3
SN - Senegal 3
TN - Tunisia 3
BB - Barbados 2
BY - Bielorussia 2
CY - Cipro 2
DZ - Algeria 2
ET - Etiopia 2
GA - Gabon 2
GY - Guiana 2
HR - Croazia 2
HU - Ungheria 2
JM - Giamaica 2
JO - Giordania 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
MK - Macedonia 2
MY - Malesia 2
OM - Oman 2
SC - Seychelles 2
A1 - Anonimo 1
BG - Bulgaria 1
CG - Congo 1
CI - Costa d'Avorio 1
CR - Costa Rica 1
EE - Estonia 1
GE - Georgia 1
GI - Gibilterra 1
IL - Israele 1
IR - Iran 1
KW - Kuwait 1
NC - Nuova Caledonia 1
NO - Norvegia 1
RO - Romania 1
SK - Slovacchia (Repubblica Slovacca) 1
SY - Repubblica araba siriana 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 22.457
Città #
Moscow 2.565
Dublin 1.304
Jacksonville 910
Santa Clara 774
Hong Kong 756
Chandler 664
Singapore 641
Bengaluru 351
Seoul 199
Princeton 179
Hefei 161
Medford 159
Bremen 144
Ashburn 130
Boardman 126
Beijing 125
Naples 111
Chicago 105
San Mateo 103
New York 102
Ann Arbor 99
Dallas 93
Caserta 90
Roxbury 83
Ho Chi Minh City 78
Istanbul 74
São Paulo 66
Woodbridge 66
Wilmington 63
The Dalles 59
Aversa 51
Camerino 45
Lyon 43
Hanoi 37
Cambridge 34
Des Moines 34
Nuremberg 34
Milan 32
Los Angeles 31
Dong Ket 30
Vienna 30
Brussels 29
London 29
Columbus 24
Munich 21
Belo Horizonte 18
Napoli 18
Nanjing 17
Rio de Janeiro 17
Rome 17
Da Nang 16
Düsseldorf 16
Amsterdam 14
Casoria 14
Mountain View 14
Curitiba 13
Helsinki 13
Houston 13
Jinan 13
Norwalk 13
Tianjin 13
Brooklyn 12
Haiphong 12
Porto Alegre 12
Tokyo 12
Ariano Irpino 11
Brasília 11
Guayaquil 11
Jakarta 11
Salvador 11
Zhengzhou 11
Council Bluffs 10
Guangzhou 10
São José dos Campos 10
Auburn Hills 9
Brno 9
Dhaka 9
Falkenstein 9
Frankfurt am Main 9
Johannesburg 9
Lima 9
San Francisco 9
Casapulla 8
Changsha 8
Marano Di Napoli 8
Quito 8
Baghdad 7
Cagliari 7
Chennai 7
Ercolano 7
Fortaleza 7
Santos 7
Shenyang 7
Tashkent 7
Venice 7
Angers 6
Ankara 6
Atlanta 6
Buenos Aires 6
Campinas 6
Totale 11.464
Nome #
Potassium depletion induces cellular conversion in the outer medullary collecting duct altering Notch signaling pathway 251
MicroRNAs in Renal Diseases: A Potential Novel Therapeutic Target 182
Big databases and biobanks for studying the links between CKD, cognitive impairment, and dementia 177
ADAM17, a New Player in the Pathogenesis of Chronic Kidney Disease–Mineral and Bone Disorder 173
The gasotransmitter hydrogen sulfide in hemodialysis patients 170
Application of proteomics and metabolomics to study inherited kidney disorders: from big data to precision medicine 162
Hyperhomocysteinemia in Chronic Renal Failure: Alternative Therapeutic Strategies 160
A case series of adult patients affected by EAST/SeSAME syndrome suggests more severe disease in subjects bearing KCNJ10 truncating mutations 158
Cytoskeletal behaviour in spectrin and in band 3 deficient spherocytic red cells: Evidence for a differentiated splenic conditioning role 157
D-amino acids in aging erythrocytes. 156
Bone composition and the birth of quantitative chemistry 155
Altered folate receptor 2 expression in uraemic patients on haemodialysis: Implications for folate resistance 155
Cognitive impairment in CKD patients: a guidance document by the CONNECT network 153
COVID-19, Low-Molecular-Weight Heparin, and Hemodialysis 153
D-aspartate content of erythrocyte membrane proteins is decreased in uremia: Implications for the repair of damaged proteins 152
Renal phenotype in bardet-biedl syndrome: A combined defect of urinary concentration and dilution is associated with defective urinary aqp2 and umod excretion 152
Atenolol vs enalapril in young hypertensive patients after successful repair of aortic coarctation 152
miRNA-23a modulates sodium-hydrogen exchanger 1 expression: studies in medullary thick ascending limb of salt induced hypertensive rats 151
Adverse effects of hyperhomocysteinemia and their management by folic acid 151
Atherosclerosis determinants in renal disease: How much is homocysteine involved? 151
Divergent behavior of hydrogen sulfide pools and of the sulfur metabolite lanthionine, a novel uremic toxin, in dialysis patients 148
Impairment of endothelial functions by acute hyperhomocysteinemia and reversal by antioxidant vitamins 146
Cardiovascular risk factors, homocysteine and folates 145
Bone mineral density assessment in patients with cystinuria 144
The Sulfur Metabolite Lanthionine: Evidence for a Role as a Novel Uremic Toxin 144
Metabolomic fingerprinting of renal disease progression in Bardet-Biedl syndrome reveals mitochondrial dysfunction in kidney tubular cells. 142
A bench to bedside view of uremic toxins 142
Nephroplex: a kidney-focused NGS panel highlights the challenges of PKD1 sequencing and identifies a founder BBS4 mutation 142
[Hyperhomocysteinemia and treatment with folates: what's new?]. 141
Looking beyond Entecavir to discover Gitelman Syndrome in a 50 year-old man 141
Long-term function of parathyroid subcutaneous autoimplantation after presumed total parathyroidectomy in the treatment of secondary hyperparathyroidism. A clinical retrospective study 139
Possible Effects of Uremic Toxins p-Cresol, Indoxyl Sulfate, p-Cresyl Sulfate on the Development and Progression of Colon Cancer in Patients with Chronic Renal Failure 139
Uremic Toxin Lanthionine Interferes with the Transsulfuration Pathway, Angiogenetic Signaling and Increases Intracellular Calcium 138
Lanthionine and Other Relevant Sulfur Amino Acid Metabolites: Detection of Prospective Uremic Toxins in Serum by Multiple Reaction Monitoring Tandem Mass Spectrometry 138
Anemia and erythropoietin in space flights 137
Characterization of five novel vasopressin V2 receptor mutants causing nephrogenic diabetes insipidus reveals a role of tolvaptan for M272R-V2R mutation 137
Dna methylation dysfunction in chronic kidney disease 137
Dapagliflozin Prevents Kidney Glycogen Accumulation and Improves Renal Proximal Tubule Cell Functions in a Mouse Model of Glycogen Storage Disease Type 1b 135
Candidate risk factors for cardiovascular disease in CKD 135
Impact of Thyroid Cancer Treatment on Renal Function: A Relevant Issue to Be Addressed 132
Gases as Uremic Toxins: Is There Something in the Air? 132
Creatinine clearance and hemoglobin concentration before and after heart transplantation 132
The heart in uremia: Role of hypertension, hypotension, and sleep apnea 131
A longitudinal study of sleep disorders in early-stage chronic kidney disease. 131
Hyperhomocysteinemia in ESRD. 130
Chitosan Gel to Treat Pressure Ulcers: A Clinical Pilot Study 130
Fabry Disease in Women: Genetic Basis, Available Biomarkers, and Clinical Manifestations 130
Corrigendum to “WCN24-1267 EMPAGLIFLOZIN IMPROVES VITALITY AND PROTECT FROM ADVANCED GLYCATION END PRODUCTS IN ENDOTHELIAL CELLS” [Kidney International Reports Volume 9, Issue 4, Supplement, April 2024, Page S637] 129
Impact of the uremic milieu on the osteogenic potential of mesenchymal stem cells 129
Two different serum MiRNA signatures correlate with the clinical outcome and histological subtype in pleural malignant mesothelioma patients 129
Homocysteine solution‐induced response in aerosol jet printed oects by means of gold and platinum gate electrodes 129
[Health care based on patients' needs]. 128
Translational research on cognitive impairment in chronic kidney disease 127
Hydrogen sulfide reduces cell adhesion and relevant inflammatory triggering by preventing ADAM17-dependent TNF-α activation 127
Hyperhomocysteinemia and protein damage in chronic renal failure and kidney transplant pediatric patients - Italian initiative on uremic hyperhomocysteinemia (IIUH) 126
BK Virus Infection and BK-Virus-Associated Nephropathy in Renal Transplant Recipients 124
The SGLT2 inhibitor dapagliflozin improves kidney function in glycogen storage disease XI 123
INIBIZIONE DELLA METIL-ESTERIFICAZIONE ENZIMATICA DELLE PROTEINE DI MEMBRANA E SUO SIGNIFICATO NELL'UREMIA:RUOLO DELL'OMOCISTEINA 123
Zebrafish as a Model of Cardiac Pathology and Toxicity: Spotlight on Uremic Toxins 122
EDEMA IN NEPHROTIC SYNDROME 122
Vasodilatation caused by endogenous hydrogen sulfide in chronic renal failure 121
[Survival is not enough: improving quality of life]. 121
Therapy of Hyperhomocysteinemia in Hemodialysis Patients: Effects of Folates and N-Acetylcysteine 120
Homocysteine and transmethylations in uremia 119
Long-term outcomes following “presumed” total parathyroidectomy for secondary hyperparathyroidism of chronic kidney disease 118
Homocysteine and chronic kidney disease: an ongoing narrative 118
The Giordano-Giovannetti diet 117
Membrane protein damage and methylation reactions in chronic renal failure 117
Uremic Toxin Lanthionine Induces Endothelial Cell Mineralization In Vitro 117
Role of parathyroidectomy on anemia control and erythropoiesis-stimulating agent need in secondary hyperparathyroidism of chronic kidney disease. A retrospective study in 30 hemodialysis patients 116
Parathyroidectomy improves the quality of sleep in maintenance hemodialysis patients with severe hyperparathyroidism 116
Impact of parathyroidectomy on cardiovascular outcomes and survival in chronic hemodialysis patients with secondary hyperparathyroidism. A retrospective study of 50 cases prior to the calcimimetics era 116
Urine concentrating defect as presenting sign of progressive renal failure in Bardet-Biedl syndrome patients 116
Decrease in parathyroid gland volume, but not in parathyroid hormone secretion, after cinacalcet treatment in a 2HPT hemodialysis patient. Case report. 115
Localization of members of MCT monocarboxylate transporter family Slc16 in the kidney and regulation during metabolic acidosis 114
Epigenetics in hyperhomocysteinemic states. A special focus on uremia 114
Homocysteinylated albumin promotes increased monocyte-endothelial cell adhesion and up-regulation of MCP1, Hsp60 and ADAM17 114
The kidney in heart failure 113
Hydrogen Sulfide, the Third Gaseous Signaling Molecule With Cardiovascular Properties, Is Decreased in Hemodialysis Patients 113
Plasma proteins containing damaged L-isoaspartyl residues are increased in uremia: Implications for mechanism 113
Phosphate depletion impairs insulin secretion by pancreatic islets 113
Integrin beta 1 is crucial for urinary concentrating ability and renal medulla architecture in adult mice 113
INSUFFICIENZA RENALE CRONICA 112
Does gut microbiota dysbiosis impact the metabolic alterations of hydrogen sulfide and lanthionine in patients with chronic kidney disease? 111
Renal function in space: The link between osteoporosis, hypercalciuria, and aquaporins 111
Low protein alimentation normalizes renal haemodynamic response to acute protein ingestion in type 1 diabetic children 111
[Hyponatremia and Electrolyte Disorders in Cancer Patients] 110
Lab on a Chip Device for Diagnostic Evaluation and Management in Chronic Renal Disease: A Change Promoting Approach in the Patients’ Follow Up 110
Review on uraemic toxins III: Recommendations for handling uraemic retention solutes in vitro - Towards a standardized approach for research on uraemia 110
Hyperhomocysteinemia in uremia - A red flag in a disrupted circuit 110
Plasma homocysteine and its determinants in diabetic retinopathy [8] 110
Plasma homocysteine and microvascular complications in type 1 diabetes 109
Homocysteine, a new cardiovascular risk factor, is also a powerful uremic toxin 109
Novel applications of lead acetate and flow cytometry methods for detection of sulfur-containing molecules 109
CKD in Bardet-Biedl Syndrome: Evidence Supporting Multifactorial Etiology 108
Plasma protein homocysteinylation in uremia 107
Occurrence of D-aspartic acid and N-methyl-D-aspartic acid in rat neuroendocrine tissues and their role in the modulation of luteinizing hormone and growth hormone release 107
The nature of water: excerpts from Pythagoras, Xenophanes, Heraclitus and Parmenides 107
Exploring Key Challenges of Understanding the Pathogenesis of Kidney Disease in Bardet–Biedl Syndrome 107
L-propionyl carnitine, homocysteine and S-adenosylhomocysteine in hemodialysis 106
Totale 13.145
Categoria #
all - tutte 74.051
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 74.051


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021828 0 0 0 0 0 13 185 149 23 191 142 125
2021/20221.120 117 10 16 49 391 15 12 24 49 60 77 300
2022/20232.573 220 48 51 213 320 196 9 138 1.214 36 56 72
2023/20241.042 96 33 45 109 356 110 41 25 12 3 71 141
2024/20253.617 116 23 48 196 496 506 606 338 440 484 208 156
2025/202610.740 584 896 616 593 1.018 7.033 0 0 0 0 0 0
Totale 22.779